Osimertinib prolongs progression-free lung cancer survival after chemotherapy.

Mike Fillon

Published in: CA: a cancer journal for clinicians (2024)

Keyphrases

small cell lung cancer
advanced non small cell lung cancer
epidermal growth factor receptor
locally advanced
squamous cell carcinoma
rectal cancer
radiation therapy
tyrosine kinase